CRNX · Categories · Form 5
CRNX - SEC Form 5 annual insider statements
Crinetics Pharmaceuticals Inc. (CRNX) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.
Recent Form 5 for CRNX
- Betz Stephen F. acquired $6,756 worth of shares (451 units at $14.98), increasing direct ownership by 0.64% to 71,358 units (SEC Form 5)5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- Wilson Marc acquired $7,086 worth of shares (473 units at $14.98), increasing direct ownership by 0.43% to 111,565 units (SEC Form 5)5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- Knight Jeff E. acquired $27,294 worth of shares (1,822 units at $14.98), increasing direct ownership by 5% to 36,222 units (SEC Form 5)5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Wilson Marc acquired $21,247 worth of shares (1,928 units at $11.02), increasing direct ownership by 2% to 83,546 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Krasner Alan Seth acquired $21,236 worth of shares (1,927 units at $11.02), increasing direct ownership by 9% to 24,488 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Knight Jeff E. acquired $8,141 worth of shares (537 units at $15.16), increasing direct ownership by 11% to 5,487 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Wilson Marc acquired $21,236 worth of shares (1,927 units at $11.02), increasing direct ownership by 3% to 62,118 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Madan Ajay acquired $8,651 worth of shares (785 units at $11.02), increasing direct ownership by 0.43% to 185,456 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Ajay Madan increased ownership by 2% to 77,516 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Seth Alan Krasner increased ownership by 29% to 6,383 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)
- SEC Form 5: Marc Wilson increased ownership by 2% to 60,191 units5 - Crinetics Pharmaceuticals, Inc. (0001658247) (Issuer)